California State Teachers Retirement System Aligos Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.04 - $2.14 $32,243 - $66,346	-31,003 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.08 - $12.2 $3,619 - $21,228	-1,740 Reduced 5.31%	31,003 $67,000
Q4 2021 Feb 15, 2022	BUY	$11.48 - $17.69 $7,083 - $10,914	617 Added 1.92%	32,743 $389,000
Q3 2021 Nov 15, 2021	BUY	$14.57 - $17.72 $90,858 - $110,501	6,236 Added 24.09%	32,126 $498,000
Q2 2021 Aug 16, 2021	BUY	$20.3 - $33.6 $199,772 - $330,657	9,841 Added 61.32%	25,890 $528,000
Q1 2021 May 18, 2021	BUY	$19.1 - $34.94 $14,878 - $27,218	779 Added 5.1%	16,049 $365,000
Q4 2020 Feb 16, 2021	BUY	$13.2 - $32.74 $201,564 - $499,939	15,270 New	15,270 $422,000

Others Institutions Holding ALGS

# of Institutions

Shares Held

253K

Call Options Held

Put Options Held

View Full List

About Aligos Therapeutics, Inc.

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $751M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

More about ALGS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account